MedPath

University of Zurich

University of Zurich logo
🇨🇭Switzerland
Ownership
Private
Established
1833-04-29
Employees
5K
Market Cap
-
Website
http://www.uzh.ch

VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)

Completed
Conditions
Macular Degeneration
Interventions
First Posted Date
2008-08-04
Last Posted Date
2015-05-28
Lead Sponsor
University of Zurich
Target Recruit Count
54
Registration Number
NCT00727753
Locations
🇨🇭

University Hospital Zurich, Division of Cardiology, Zurich, ZH, Switzerland

Evaluation of Safety, Tolerability, Immunogenicity and Efficacy of a Novel Method in Specific Immunotherapy in Cat Allergic Patients: a Placebo Controlled Trial

Phase 1
Completed
Conditions
Allergy to Cat Dander
Interventions
Drug: Placebo
First Posted Date
2008-07-21
Last Posted Date
2010-02-11
Lead Sponsor
University of Zurich
Target Recruit Count
20
Registration Number
NCT00718679
Locations
🇨🇭

Center for Clinical Research University Hospital Zurich, Zurich, Switzerland

Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration

Phase 2
Completed
Conditions
Allergies
Interventions
Drug: Purified allergen dose 3 integrated in a Patch system
Drug: Purified allergen integrated in a Patch system
Drug: Purified allergen dose 1 integrated in a Patch system
Drug: Purified allergen dose 2 integrated in a Patch system
First Posted Date
2008-07-21
Last Posted Date
2011-02-17
Lead Sponsor
University of Zurich
Target Recruit Count
132
Registration Number
NCT00719511

Functional Recovery in Stroke Patients With Task-Specific Robot-Aided Arm Therapy

Phase 2
Completed
Conditions
Stroke
Upper Extremity Paresis
First Posted Date
2008-07-21
Last Posted Date
2013-04-22
Lead Sponsor
University of Zurich
Target Recruit Count
76
Registration Number
NCT00719433
Locations
🇨🇭

University Hospital Balgrist, Zürich, ZH, Switzerland

Pharmacokinetic Study: Effect of 25(OH)D and Vitamin D3 on Serum 25(OH)D

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: 25(OH)D
Dietary Supplement: vitamin D3
First Posted Date
2008-07-18
Last Posted Date
2011-12-23
Lead Sponsor
University of Zurich
Target Recruit Count
35
Registration Number
NCT00718276
Locations
🇨🇭

University Hospital Zurich, Centre on Aging and Mobility, Zurich, ZH, Switzerland

Treatment of Patients With the Obstructive Sleep Apnea Syndrome at Altitude

Phase 4
Completed
Conditions
Obstructive Sleep Apnea Syndrome
First Posted Date
2008-07-14
Last Posted Date
2014-05-20
Lead Sponsor
University of Zurich
Target Recruit Count
49
Registration Number
NCT00714740
Locations
🇨🇭

Pulmonary Division, University Hospital Zurich, Zurich, Switzerland

Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma

Phase 1
Completed
Conditions
Recurrent Glioblastoma Planned for Reoperation
First Posted Date
2008-07-14
Last Posted Date
2011-09-15
Lead Sponsor
University of Zurich
Target Recruit Count
9
Registration Number
NCT00715013

Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery

Phase 4
Terminated
Conditions
Iron Deficiency Anemia
Interventions
Drug: Ferinject ®
First Posted Date
2008-06-27
Last Posted Date
2013-06-20
Lead Sponsor
University of Zurich
Target Recruit Count
75
Registration Number
NCT00706667
Locations
🇨🇭

University Hospital Zurich, Division of Anaesthesiology, Zurich, ZH, Switzerland

Predicting the Course of Chronic Obstructive Pulmonary Disease (COPD) in Primary Care

Conditions
COPD
First Posted Date
2008-06-27
Last Posted Date
2010-06-28
Lead Sponsor
University of Zurich
Target Recruit Count
450
Registration Number
NCT00706602
Locations
🇨🇭

Institute for primary care, University of Zurich, Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath